{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:06:13Z","timestamp":1768082773665,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.vaccine.2009.04.008","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T08:35:31Z","timestamp":1240562131000},"page":"3821-3830","source":"Crossref","is-referenced-by-count":15,"title":["Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera"],"prefix":"10.1016","volume":"27","author":[{"given":"Guifang","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuhu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"September (5177)","key":"10.1016\/j.vaccine.2009.04.008_bib1","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.8073279","article-title":"Cholera vaccines: fighting an ancient scourge","volume":"265","author":"Mekalanos","year":"1994","journal-title":"Science"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.04.008_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/CMR.8.1.48","volume":"8","author":"Kaper","year":"1995","journal-title":"Clin Microbiol Rev"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2009.04.008_bib3","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1101\/gad.11.14.1761","article-title":"Survival in a cruel world: how Vibrio cholerae and Salmonella respond to an unwilling host","volume":"11","author":"Slauch","year":"1997","journal-title":"Genes Dev"},{"issue":"December (13)","key":"10.1016\/j.vaccine.2009.04.008_bib4","first-page":"R157","article-title":"Cholera: current epidemiology","volume":"4","author":"Crowcroft","year":"1994","journal-title":"Commun Dis Rep CDR Rev"},{"key":"10.1016\/j.vaccine.2009.04.008_bib5","unstructured":"WHO. http:\/\/ochaonline.un.org\/Default.aspx?alias=ochaonline.un.org\/zimbabwe. January 3, 2009."},{"issue":"December (5943)","key":"10.1016\/j.vaccine.2009.04.008_bib6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/306551a0","article-title":"Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development","volume":"306","author":"Mekalanos","year":"1983","journal-title":"Nature"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.04.008_bib7","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1073\/pnas.75.6.2669","article-title":"Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system","volume":"75","author":"Cassel","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.04.008_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.mi.22.100168.001333","article-title":"Cholera toxins","volume":"22","author":"Burrows","year":"1968","journal-title":"Annu Rev Microbiol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.04.008_bib9","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/cbdv.200490078","article-title":"Progress towards development of a cholera subunit vaccine","volume":"1","author":"Taylor","year":"2004","journal-title":"Chem Biodivers"},{"issue":"January (9404)","key":"10.1016\/j.vaccine.2009.04.008_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0140-6736(03)15328-7","article-title":"Cholera","volume":"363","author":"Sack","year":"2004","journal-title":"Lancet"},{"issue":"July\u2013August (1\u20132)","key":"10.1016\/j.vaccine.2009.04.008_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4269\/ajtmh.2000.63.12","article-title":"Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh","volume":"63","author":"Ryan","year":"2000","journal-title":"Am J Trop Med Hyg"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.04.008_bib12","first-page":"419","article-title":"Epidemic cholera in Latin America: spread and routes of transmission","volume":"98","author":"Guthmann","year":"1995","journal-title":"J Trop Med Hyg"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2009.04.008_bib13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/313951","article-title":"Cholera vaccines","volume":"31","author":"Ryan","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.04.008_bib14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1586\/14760584.5.6.751","article-title":"Present and future cholera vaccines","volume":"5","author":"Olsson","year":"2006","journal-title":"Expert Rev Vaccines"},{"issue":"May (18)","key":"10.1016\/j.vaccine.2009.04.008_bib15","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1016\/j.vaccine.2006.03.039","article-title":"Enteric infections and the vaccines to counter them: future directions","volume":"24","author":"Levine","year":"2006","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.04.008_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(06)70494-7","article-title":"Oral cholera vaccines: use in clinical practice","volume":"6","author":"Hill","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2009.04.008_bib17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1586\/14760584.5.4.483","article-title":"Live attenuated oral cholera vaccines","volume":"5","author":"Ryan","year":"2006","journal-title":"Expert Rev Vaccines"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2009.04.008_bib18","first-page":"325","article-title":"A review of the current status of enteric vaccines","volume":"38","author":"Levine","year":"1995","journal-title":"PNG Med J"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.008_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0264-410X(92)90030-N","article-title":"Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers","volume":"10","author":"Jertborn","year":"1992","journal-title":"Vaccine"},{"issue":"September (12)","key":"10.1016\/j.vaccine.2009.04.008_bib20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/0264-410X(94)90176-7","article-title":"Immunological memory after immunization with oral cholera B subunit\u2014whole-cell vaccine in Swedish volunteers","volume":"12","author":"Jertborn","year":"1994","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2009.04.008_bib21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0264-410X(93)90125-H","article-title":"Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers","volume":"11","author":"Jertborn","year":"1993","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.04.008_bib22","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1128\/IAI.69.6.4125-4128.2001","article-title":"Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans","volume":"69","author":"Jertborn","year":"2001","journal-title":"Infect Immun"},{"issue":"May (22)","key":"10.1016\/j.vaccine.2009.04.008_bib23","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.04.008_bib24","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/IAI.70.4.1965-1970.2002","article-title":"Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine","volume":"70","author":"Cohen","year":"2002","journal-title":"Infect Immun"},{"issue":"June (19)","key":"10.1016\/j.vaccine.2009.04.008_bib25","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.vaccine.2003.12.033","article-title":"Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR","volume":"22","author":"Viret","year":"2004","journal-title":"Vaccine"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2009.04.008_bib26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0958-1669(94)90035-3","article-title":"Live bacterial vaccines: environmental aspects","volume":"5","author":"Mekalanos","year":"1994","journal-title":"Curr Opin Biotechnol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.04.008_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/IAI.56.1.161-167.1988","article-title":"Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques","volume":"56","author":"Levine","year":"1988","journal-title":"Infect Immun"},{"issue":"August (8609)","key":"10.1016\/j.vaccine.2009.04.008_bib28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(88)90120-1","article-title":"Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR","volume":"2","author":"Levine","year":"1988","journal-title":"Lancet"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.04.008_bib29","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1128\/IAI.67.7.3680-3685.1999","article-title":"Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria","volume":"67","author":"Viret","year":"1999","journal-title":"Infect Immun"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2009.04.008_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2004.11.009","article-title":"Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA","volume":"97","author":"Holmgren","year":"2005","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.008_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/rmv.307","article-title":"Mucosal immune network in the gut for the control of infectious diseases","volume":"11","author":"Iijima","year":"2001","journal-title":"Rev Med Virol"},{"issue":"May (21)","key":"10.1016\/j.vaccine.2009.04.008_bib32","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1016\/j.vaccine.2005.08.023","article-title":"Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2009.04.008_bib33","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1073\/pnas.90.18.8392","article-title":"Production of high-titer helper-free retroviruses by transient transfection","volume":"90","author":"Pear","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2009.04.008_bib34","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2008.02.033","article-title":"The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.04.008_bib35","doi-asserted-by":"crossref","first-page":"7695","DOI":"10.1128\/IAI.69.12.7695-7702.2001","article-title":"Evaluation of cholera vaccines formulated with toxin-coregulated pilin peptide plus polymer adjuvant in mice","volume":"69","author":"Wu","year":"2001","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.04.008_bib36","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/infdis\/161.6.1231","article-title":"Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model","volume":"161","author":"Sun","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.04.008_bib37","first-page":"31","article-title":"Oral administration of immunomodulators and the mucosal immune system","volume":"77","author":"Revillard","year":"1992","journal-title":"Dev Biol Stand"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2009.04.008_bib38","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1128\/JVI.79.12.7933-7937.2005","article-title":"Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1","volume":"79","author":"Wang","year":"2005","journal-title":"J Virol"},{"issue":"June (1)","key":"10.1016\/j.vaccine.2009.04.008_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2006.02.032","article-title":"Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E","volume":"350","author":"Wang","year":"2006","journal-title":"Virology"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2009.04.008_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00281-006-0028-1","article-title":"Combination DNA plus protein HIV vaccines","volume":"28","author":"Lu","year":"2006","journal-title":"Springer Semin Immunopathol"},{"issue":"May (2)","key":"10.1016\/j.vaccine.2009.04.008_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.virol.2005.12.029","article-title":"Immunization of rhesus macaques with a polyvalent DNA prime\/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype","volume":"348","author":"Pal","year":"2006","journal-title":"Virology"},{"issue":"July (31\u201332)","key":"10.1016\/j.vaccine.2009.04.008_bib42","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1016\/j.vaccine.2006.04.065","article-title":"Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization","volume":"24","author":"Herrmann","year":"2006","journal-title":"Vaccine"},{"issue":"July (13)","key":"10.1016\/j.vaccine.2009.04.008_bib43","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1128\/JVI.00068-08","article-title":"Multifunctional T-cell characteristics induced by a polyvalent DNA prime\/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration","volume":"82","author":"Bansal","year":"2008","journal-title":"J Virol"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2009.04.008_bib44","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.vaccine.2007.12.024","article-title":"Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2009.04.008_bib45","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1128\/JVI.79.14.8812-8827.2005","article-title":"Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1","volume":"79","author":"Beddows","year":"2005","journal-title":"J Virol"},{"issue":"August (15)","key":"10.1016\/j.vaccine.2009.04.008_bib46","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1128\/JVI.00562-08","article-title":"Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccination","volume":"82","author":"Vaine","year":"2008","journal-title":"J Virol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2009.04.008_bib47","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4049\/jimmunol.162.2.821","article-title":"Deficiency of IL-5 receptor alpha-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa-associated tissues","volume":"162","author":"Hiroi","year":"1999","journal-title":"J Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.04.008_bib48","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0167-5699(95)80047-6","article-title":"Involvement of B-1 cells in mucosal immunity and autoimmunity","volume":"16","author":"Murakami","year":"1995","journal-title":"Immunol Today"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09005374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09005374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T22:46:47Z","timestamp":1684968407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09005374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":48,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0264410X09005374"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.04.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}